Suppr超能文献

相似文献

1
Factors affecting the visual outcome in acute central serous chorioretinopathy.
Pak J Med Sci. 2017 Jan-Feb;33(1):3-7. doi: 10.12669/pjms.331.11664.
2
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Am J Ophthalmol. 2016 Oct;170:91-99. doi: 10.1016/j.ajo.2016.07.026. Epub 2016 Aug 9.
3
Clinical factors related to visual outcome in central serous chorioretinopathy.
Retina. 2010 Jul-Aug;30(7):1128-34. doi: 10.1097/IAE.0b013e3181cdf381.
5
Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Semin Ophthalmol. 2018;33(5):690-699. doi: 10.1080/08820538.2017.1416414. Epub 2017 Dec 18.
7
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.
J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):61-5. doi: 10.4103/2008-322X.180700.
9
A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
Br J Ophthalmol. 2015 Jun;99(6):848-52. doi: 10.1136/bjophthalmol-2014-306018. Epub 2015 Jan 16.
10
The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy.
J Ocul Pharmacol Ther. 2013 Feb;29(1):10-3. doi: 10.1089/jop.2012.0072. Epub 2012 Aug 27.

引用本文的文献

本文引用的文献

1
Advances in the treatment of central serous chorioretinopathy.
Saudi J Ophthalmol. 2015 Oct-Dec;29(4):278-86. doi: 10.1016/j.sjopt.2015.01.007. Epub 2015 Jan 24.
2
3
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.
Prog Retin Eye Res. 2015 Sep;48:82-118. doi: 10.1016/j.preteyeres.2015.05.003. Epub 2015 May 27.
4
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
Eye (Lond). 2015 Jun;29(6):732-40; quiz 741. doi: 10.1038/eye.2015.58. Epub 2015 May 8.
5
[Central serous chorioretinopathy: clinical-anatomic correlations].
J Fr Ophtalmol. 2014 Dec;37(10):787-95. doi: 10.1016/j.jfo.2014.05.007. Epub 2014 Oct 11.
6
Topical nepafenac in treatment of acute central serous chorioretinopathy.
Med Hypothesis Discov Innov Ophthalmol. 2013 Winter;2(4):96-101.
8
Does microperimetry have a prognostic value in central serous chorioretinopathy?
Retina. 2014 Apr;34(4):713-8. doi: 10.1097/IAE.0b013e3182a323fe.
9
Central serous chorioretinopathy: update on pathophysiology and treatment.
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验